Objective: to evaluate the role of US &CT guided percutanous renal biopsy (PRB) in diagnosis and monitoring of renal parenchymal diseases. Patients &Methods: This study included 30 patients who were presented by and/or known cases of renal parenchymal disease referred for US and/or CT guided PRB for etiological & histopathological diagnosis. The histopathological results were correlated with clinical, US & laboratory data for each patient. Results: Out of those 30 patients; 29 patients had adequate PRB (29/30) (96.7%) for histopatholgical diagnosis. Out of those 29 patients; 23 showed increase in renal cortical echogenicity (13 with GI, 8 with GII, &2 with GIII) & 6 cases showed normal echogenicity (G0). The lupus nephritis was the most accounted diagnosis (16/29) (55.2%)(7 with GI, 5 with GII, 4 with G0 cortical echogenicity). The glomerular changes were depicted in 25 cases (13 with GI, 7 with GII, 2 with GIII, 3 with G0), tubular changes in 21 cases (10 with GI, 7 with GII, 2 with GI, 2 with G0), and interstitial changes in 24 cases (12 with GI, 8 with GII, 2 with GIII, 2 with G0). Post biopsy complications (minor) were accounted only in 2 cases (2/30) (6.7%). Conclusions: Ultrasound PRB is the standard method for most non-focal renal biopsies as it has the advantage of real-time needle placement without radiation & fundamental procedure for diagnosis, monitoring &treatment of RPD. US and CT guided PRB is generally considered safe with minimal risk.
Published in | International Journal of Medical Imaging (Volume 3, Issue 6) |
DOI | 10.11648/j.ijmi.20150306.13 |
Page(s) | 114-129 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2015. Published by Science Publishing Group |
Ultrasound Guided, Renal Biopsy, CT Guided, Renal Parenchymal Disease
[1] | Stevens PE, O'Donoghue DJ, de LS et al. Chronic kidney disease management in the UnitedKingdom: NEOERICA project results. Kidney Int 2007; 72(1): 92-99. |
[2] | Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41(1): 1-12. |
[3] | Barsoum RS. End-stage renal disease in North Africa. Kidney Int Suppl 2003; (83): S111-S114. |
[4] | Fiorini F, Barozzi L. The role of ultrasonography in the study of medical nephropathy. Journal of Ultrasound 2007; 10(4): 161-167. |
[5] | Buturovi-ç-Ponikvar J, Visnar-Perovic A. Ultrasonography in chronic renal failure. Eur J Radiol 2003; 46(2): 115-122. |
[6] | Alebiosu CO, Kadiri S. Percutaneous renal biopsy as an outpatient procedure. J Natl Med Assoc 2004; 96(9): 1215-1218. |
[7] | Salama AD. Renal biopsy. Medicine 2011; 39(6): 339-342. |
[8] | Uppot RN, Harisinghani MG, Gervais DA. Imaging-guided percutaneous renal biopsy: rationale and approach. AJR Am J Roentgenol 2010; 194(6): 1443-1449. |
[9] | Garg AK, Kanitkar M, Venkateshwar V. Clinicopathological spectrum of renal biopsies in children. Medical Journal Armed Forces India 2010; 66(3): 216-219. |
[10] | Riccabona M, Mache C, Ring E. Renal Parenchymal Disease. In: Fotter R, editor. Pediatric Uroradiology.Berlin, Heidelberg: Springer; 2008. 355-383 |
[11] | Waldo B, Korbet SM, Freimanis MG, Lewis EJ. The value of post-biopsy ultrasound in predicting complications after percutaneous renal biopsy of native kidneys. Nephrology Dialysis Transplantation 2009; 24(8): 2433-2439. |
[12] | Atwell TD, Smith RL, Hesley GK et al. Incidence of bleeding after 15,181 percutaneous biopsies and the role of aspirin. AJR Am J Roentgenol 2010; 194(3): 784-789. |
[13] | Chan KW, Chan TM, Cheng IK. Clinical and pathological characteristics of patients with glomerular diseases at a university teaching hospital: 5-year prospective review. Hong Kong Med J 1999; 5(3): 240-244. |
[14] | Rahbar M. Kidney biopsy in west of Iran: Complications and histopathological findings. Indian J Nephrol 2009; 19(2): 68-70. |
[15] | Francis M, Barsoum R. Spectrum of Glomerulonephritis in Egypt. Saudi J Kidney Dis Transpl 2000; 11(3): 421-429. |
[16] | Al Arrayed A, George SM, Malik AK et al. The spectrum of glomerular diseases in the kingdom of bahrain: An epidemiological study based on renal biopsy interpretation. Transplantation proceedings 2004; 36(6): 1792-1795. |
[17] | Shawarby M, Al Tamimi D, Al Mueilo S et al. A Clinicopathologic Study of Glomerular Disease: Experience of the King Fahd Hospital of the University, Eastern Province, Saudi Arabia. Hong Kong Journal of Nephrology 2010; 12(1): 20-30. |
[18] | Ossareh S, Asgari M, Abdi E et al. Renal biopsy findings in Iran: case series report from a referral kidney center. Int Urol Nephrol 2010; 42(4): 1031-1040. |
[19] | Tang S, Li JH, Lui SL, Chan TM, Cheng IK, Lai KN. Free-hand, ultrasound-guided percutaneous renal biopsy: experience from a single operator. Eur J Radiol 2002; 41(1): 65-69. |
[20] | Torres MA, Valdez-Ortiz R, Gonzalez-Parra C et al. Percutaneous renal biopsy of native kidneys: Effeciency, saftey, & risk factors associated with major complications. Arch Med Sci 2011; 7 (5): 823-831. |
[21] | Sugiyama H, Yokoyama H, Sato H et al. Japan Renal Biopsy Registry: the first nationwide, web-based, and prospective registry system of renal biopsies in Japan. Clin Exp Nephrol 2011; 15(4): 493-503. |
[22] | Burstein DM, Korbet SM, Schwartz MM. The use of the automatic core biopsy system in percutaneous renal biopsies: a comparative study. Am J Kidney Dis 1993; 22(4): 545-552. |
[23] | Corwin HL, Schwartz MM, Lewis EJ. The importance of sample size in the interpretation of the renal biopsy. Am J Nephrol 1988; 8(2): 85-89. |
[24] | Castro R, Sequeira MJ, Sameiro FM et al. Percutaneous kidney biopsy: eight years-experience. Acta Med Port 2004; 17(1): 20-26. |
[25] | Gonzalez-Michaca L, Chew-Wong A, Soltero L, Gamba G, Correa-Rotter R. Percutaneous kidney biopsy, analysis of 26 years: complication rate and risk factors; comment. Rev Invest Clin 2000; 52(2): 125-131. |
[26] | Mishra A, Tarsin R, Elhabbash B et al. Percutaneous ultrasound-guided renal biopsy. Saudi J Kidney Dis Transpl 2011; 22(4): 746-750. |
[27] | Whittier WL, Korbet SM. Timing of complications in percutaneous renal biopsy. J Am Soc Nephrol 2004; 15(1): 142-147. |
[28] | Manno C, Strippoli GF, Arnesano L et al. Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int 2004; 66(4): 1570-1577. |
[29] | Eiro M, Katoh T, Watanabe T. Risk factors for bleeding complications in percutaneous renal biopsy. Clin Exp Nephrol 2005; 9(1): 40-45. |
[30] | Bach D, Wirth C, Schott G, Hollenbeck M, Grabensee B. Percutaneous renal biopsy: three years of experience with the biopty gun in 761 cases--a survey of results and complications. Int Urol Nephrol 1999; 31(1): 15-22. |
[31] | Simckes AM, Blowey DL, Gyves KM, Alon US. Success and safety of same-day kidney biopsy in children and adolescents. Pediatr Nephrol 2000; 14(10-11): 946-952. |
[32] | Moghazi S, Jones E, Schroepple J et al. Correlation of renal histopathology with sonographic findings. Kidney Int 2005; 67(4): 1515-1520. |
[33] | Rosenfield AT, Siegel NJ. Renal parenchymal disease: histopathologic-sonographic correlation. American Journal of Roentgenology 1981; 137(4): 793-798. |
APA Style
Atef Hammad Teama, Kamal Mohamed Okasha, Sameh Ahmed Khodair, Rehab Mohamed EL-Nagar. (2015). Ultrasonography and CT Guided Percutaneous Renal Biopsy in Diagnosis of Renal Parenchymal Diseases. International Journal of Medical Imaging, 3(6), 114-129. https://doi.org/10.11648/j.ijmi.20150306.13
ACS Style
Atef Hammad Teama; Kamal Mohamed Okasha; Sameh Ahmed Khodair; Rehab Mohamed EL-Nagar. Ultrasonography and CT Guided Percutaneous Renal Biopsy in Diagnosis of Renal Parenchymal Diseases. Int. J. Med. Imaging 2015, 3(6), 114-129. doi: 10.11648/j.ijmi.20150306.13
AMA Style
Atef Hammad Teama, Kamal Mohamed Okasha, Sameh Ahmed Khodair, Rehab Mohamed EL-Nagar. Ultrasonography and CT Guided Percutaneous Renal Biopsy in Diagnosis of Renal Parenchymal Diseases. Int J Med Imaging. 2015;3(6):114-129. doi: 10.11648/j.ijmi.20150306.13
@article{10.11648/j.ijmi.20150306.13, author = {Atef Hammad Teama and Kamal Mohamed Okasha and Sameh Ahmed Khodair and Rehab Mohamed EL-Nagar}, title = {Ultrasonography and CT Guided Percutaneous Renal Biopsy in Diagnosis of Renal Parenchymal Diseases}, journal = {International Journal of Medical Imaging}, volume = {3}, number = {6}, pages = {114-129}, doi = {10.11648/j.ijmi.20150306.13}, url = {https://doi.org/10.11648/j.ijmi.20150306.13}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijmi.20150306.13}, abstract = {Objective: to evaluate the role of US &CT guided percutanous renal biopsy (PRB) in diagnosis and monitoring of renal parenchymal diseases. Patients &Methods: This study included 30 patients who were presented by and/or known cases of renal parenchymal disease referred for US and/or CT guided PRB for etiological & histopathological diagnosis. The histopathological results were correlated with clinical, US & laboratory data for each patient. Results: Out of those 30 patients; 29 patients had adequate PRB (29/30) (96.7%) for histopatholgical diagnosis. Out of those 29 patients; 23 showed increase in renal cortical echogenicity (13 with GI, 8 with GII, &2 with GIII) & 6 cases showed normal echogenicity (G0). The lupus nephritis was the most accounted diagnosis (16/29) (55.2%)(7 with GI, 5 with GII, 4 with G0 cortical echogenicity). The glomerular changes were depicted in 25 cases (13 with GI, 7 with GII, 2 with GIII, 3 with G0), tubular changes in 21 cases (10 with GI, 7 with GII, 2 with GI, 2 with G0), and interstitial changes in 24 cases (12 with GI, 8 with GII, 2 with GIII, 2 with G0). Post biopsy complications (minor) were accounted only in 2 cases (2/30) (6.7%). Conclusions: Ultrasound PRB is the standard method for most non-focal renal biopsies as it has the advantage of real-time needle placement without radiation & fundamental procedure for diagnosis, monitoring &treatment of RPD. US and CT guided PRB is generally considered safe with minimal risk.}, year = {2015} }
TY - JOUR T1 - Ultrasonography and CT Guided Percutaneous Renal Biopsy in Diagnosis of Renal Parenchymal Diseases AU - Atef Hammad Teama AU - Kamal Mohamed Okasha AU - Sameh Ahmed Khodair AU - Rehab Mohamed EL-Nagar Y1 - 2015/11/19 PY - 2015 N1 - https://doi.org/10.11648/j.ijmi.20150306.13 DO - 10.11648/j.ijmi.20150306.13 T2 - International Journal of Medical Imaging JF - International Journal of Medical Imaging JO - International Journal of Medical Imaging SP - 114 EP - 129 PB - Science Publishing Group SN - 2330-832X UR - https://doi.org/10.11648/j.ijmi.20150306.13 AB - Objective: to evaluate the role of US &CT guided percutanous renal biopsy (PRB) in diagnosis and monitoring of renal parenchymal diseases. Patients &Methods: This study included 30 patients who were presented by and/or known cases of renal parenchymal disease referred for US and/or CT guided PRB for etiological & histopathological diagnosis. The histopathological results were correlated with clinical, US & laboratory data for each patient. Results: Out of those 30 patients; 29 patients had adequate PRB (29/30) (96.7%) for histopatholgical diagnosis. Out of those 29 patients; 23 showed increase in renal cortical echogenicity (13 with GI, 8 with GII, &2 with GIII) & 6 cases showed normal echogenicity (G0). The lupus nephritis was the most accounted diagnosis (16/29) (55.2%)(7 with GI, 5 with GII, 4 with G0 cortical echogenicity). The glomerular changes were depicted in 25 cases (13 with GI, 7 with GII, 2 with GIII, 3 with G0), tubular changes in 21 cases (10 with GI, 7 with GII, 2 with GI, 2 with G0), and interstitial changes in 24 cases (12 with GI, 8 with GII, 2 with GIII, 2 with G0). Post biopsy complications (minor) were accounted only in 2 cases (2/30) (6.7%). Conclusions: Ultrasound PRB is the standard method for most non-focal renal biopsies as it has the advantage of real-time needle placement without radiation & fundamental procedure for diagnosis, monitoring &treatment of RPD. US and CT guided PRB is generally considered safe with minimal risk. VL - 3 IS - 6 ER -